Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aktis Oncology, Inc. (AKTS) vs. Competitors

43 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AKTSAktis Oncology, Inc.$16.31$907.15M-10.20-27.19%Strong BuyUnlock the AKTS analyst price target with TipRanks PremiumAKTSUnlock the AKTS top-analyst price target with TipRanks Premium
IOVAIovance Biotherapeutics$7.53$3.48B-14.07211.16%Strong BuyUnlock the IOVA analyst price target with TipRanks PremiumAKTS vs IOVAUnlock the IOVA top-analyst price target with TipRanks Premium
ZYMEZymeworks$25.84$1.80B38.328.12%Strong BuyUnlock the ZYME analyst price target with TipRanks PremiumAKTS vs ZYMEUnlock the ZYME top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$8.00$831.45M-5.35-33.67%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumAKTS vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
IMCRImmunocore Holdings$27.81$1.44B-43.79-23.95%Moderate BuyUnlock the IMCR analyst price target with TipRanks PremiumAKTS vs IMCRUnlock the IMCR top-analyst price target with TipRanks Premium
NBTXNanobiotix$27.45$1.38B-22.4525.40%Moderate BuyUnlock the NBTX analyst price target with TipRanks PremiumAKTS vs NBTXUnlock the NBTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%500%600%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AKTSAktis Oncology, Inc.16.31-6.09-27.19%
IOVAIovance Biotherapeutics7.535.09208.61%
ZYMEZymeworks25.842.8512.40%
ORICOric Pharmaceuticals8.00-3.90-32.77%
IMCRImmunocore Holdings27.81-10.25-26.93%
NBTXNanobiotix27.455.6525.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts